FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...